# Biological Effects of Agent on PAR-4 Levels With Resected Solid Tumors

> **NCT03015324** · PHASE1 · COMPLETED · sponsor: **Peng Wang, MD PhD** · enrollment: 38 (actual)

## Conditions studied

- Solid Tumor

## Interventions

- **DRUG:** Hydroxychloroquine

## Key facts

- **NCT ID:** NCT03015324
- **Lead sponsor:** Peng Wang, MD PhD
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-08-08
- **Primary completion:** 2020-02-03
- **Final completion:** 2021-02-02
- **Target enrollment:** 38 (ACTUAL)
- **Last updated:** 2022-01-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03015324

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03015324, "Biological Effects of Agent on PAR-4 Levels With Resected Solid Tumors". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT03015324. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*